UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Managing Metastatic Melanoma in 2022: A Clinical Review

JCO oncology practice, 2022-05, Vol.18 (5), p.335-351

2022

Link zum Volltext

Verfügbarkeit prüfen

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Nature communications, 2021-03, Vol.12 (1), p.1402-1402, Article 1402

2021

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

The lancet oncology, 2012-05, Vol.13 (5), p.459-465

2012

Link zum Volltext

Verfügbarkeit prüfen

Purity and yield of melanoma exosomes are dependent on isolation method

Journal of extracellular vesicles, 2020-01, Vol.9 (1), p.1692401-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies

Frontiers in immunology, 2021-04, Vol.12, p.638111-638111

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of artificial intelligence chatbots in clinical management of immune-related adverse events

Journal for immunotherapy of cancer, 2024-05, Vol.12 (5), p.e008599

2024

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Frontiers in oncology, 2021-04, Vol.11, p.679177

2021

Link zum Volltext

Verfügbarkeit prüfen

Tracking antigen-driven responses by flow cytometry: Monitoring proliferation by dye dilution

Cytometry. Part A, 2008-11, Vol.73A (11), p.1019-1034

2008

Link zum Volltext

Verfügbarkeit prüfen

Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma

Targeted oncology, 2018-10, Vol.13 (5), p.599-609

2018

Link zum Volltext

Verfügbarkeit prüfen

Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management

American Society of Clinical Oncology educational book, 2018-05, Vol.38 (38), p.239-247

2018

Link zum Volltext

Verfügbarkeit prüfen

Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment

Scientific reports, 2018-08, Vol.8 (1), p.12905-14, Article 12905

2018

Link zum Volltext

Verfügbarkeit prüfen

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival

Cancer Immunology, Immunotherapy, 2018-07, Vol.67 (7), p.1113-1121

2018

Link zum Volltext

Verfügbarkeit prüfen

Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report

Medicine (Baltimore), 2019-11, Vol.98 (44), p.e17769-e17769

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression

Cancer immunology research, 2019-09, Vol.7 (9), p.1497-1510

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma

Investigational new drugs, 2013-08, Vol.31 (4), p.937-942

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (11), p.1961-1973

2021

Link zum Volltext

Verfügbarkeit prüfen

A Rapid Exosome Isolation Using Ultrafiltration and Size Exclusion Chromatography (REIUS) Method for Exosome Isolation from Melanoma Cell Lines

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2265, p.289

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.73-73, Article 73

2019

Link zum Volltext

Verfügbarkeit prüfen

Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor

Oncotarget, 2017-09, Vol.8 (40), p.67754-67768

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth

Oncology reports, 2023-02, Vol.49 (2), p.1, Article 44

2023

Link zum Volltext

Verfügbarkeit prüfen

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

International journal of epidemiology, 2009-06, Vol.38 (3), p.814-830

2009

Link zum Volltext

Verfügbarkeit prüfen

Systemic coagulation is activated in patients with meningioma and glioblastoma

Journal of neuro-oncology, 2021-11, Vol.155 (2), p.173-180

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme

Neuro-oncology (Charlottesville, Va.), 2011-04, Vol.13 (4), p.393-400

2011

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-based immunotherapy for glioblastoma

CNS oncology, 2013-07, Vol.2 (4), p.331-349

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

ThemaImmunotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(79)
Humans
(73)
Oncology
(47)
Male
(40)
Female
(37)
Middle Aged
(32)
Aged
(30)
Biological And Medical Sciences
(28)
Melanoma
(27)
Adult
(24)
Medical Sciences
(23)
Tumors
(18)
Immunology
(16)
Dermatology
(13)
Animals
(11)
Melanoma - Pathology
(11)
Skin Neoplasms - Pathology
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Flow Cytometry
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

Managing Metastatic Melanoma in 2022: A Clinical Review

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Purity and yield of melanoma exosomes are dependent on isolation method

Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies

Use of artificial intelligence chatbots in clinical management of immune-related adverse events

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Tracking antigen-driven responses by flow cytometry: Monitoring proliferation by dye dilution

Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma

Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management

Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival

Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report

Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression

Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

A Rapid Exosome Isolation Using Ultrafiltration and Size Exclusion Chromatography (REIUS) Method for Exosome Isolation from Melanoma Cell Lines

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor

Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

Systemic coagulation is activated in patients with meningioma and glioblastoma

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme

Vaccine-based immunotherapy for glioblastoma

Aktive Filter

Suchergebnisse filtern